Low Vitamin K1 (cas 11104-38-4) intake in haemodialysis patients

Add time:07/21/2019    Source:sciencedirect.com

SummaryBackground & aimsVitamin K acts as a coenzyme in the γ-carboxylation of vitamin K-dependent proteins, including coagulation factors, osteocalcin, matrix Gla protein (MGP), and the growth arrest-specific 6 (GAS6) protein. Osteocalcin is a key factor for bone matrix formation. MGP is a local inhibitor of soft tissue calcification. GAS6 activity prevents the apoptosis of vascular smooth muscle cells. Few data on vitamin K intake in chronic kidney disease patients and no data in patients on a Mediterranean diet are available. In the present study, we evaluate the dietary intake of Vitamin K1 (cas 11104-38-4) in a cohort of patients undergoing haemodialysis.

We also recommend Trading Suppliers and Manufacturers of Vitamin K1 (cas 11104-38-4). Pls Click Website Link as below: cas 11104-38-4 suppliers

Prev:Cytoprotective and genotoxic effects of vitamins K1 and B1 on irinotecan in vitro
Next:Development of nanoemulsions for topical delivery of Vitamin K1 (cas 11104-38-4))